The Food and Drug Administration announced earlier this week that it would add stronger warning labels to Yaz, Yasmin and other birth control pills containing drospirenone (a synthetic version of the hormone progesterone) about the associated risk of blood clots. But, the FDA emphasized, the risk is still small; smaller, in fact, than the risk of blood clots during pregnancy or the postpartum period, and small enough that women taking the pill shouldn't worry and should "continue taking their pills as directed unless told otherwise by their healthcare professional.
The FDA informs that new data regarding birth control pills containing drospirenone are being evaluated to determine what the risk of blood clots is. Drospirenone is a synthetic progestin - a female sex hormone. Birth control pills ... Read Post
The U.S. Food and Drug Administration (FDA) is informing the public about new information 1,2 that is being assessed as part of FDA's ongoing safety review of birth control pills that contain drospirenone. This review will further e... Read Post